Form 8-K - Current report:
SEC Accession No. 0001193125-24-230760
Filing Date
2024-10-02
Accepted
2024-10-02 09:01:59
Documents
56
Period of Report
2024-10-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d802938d8k.htm   iXBRL 8-K 28085
2 EX-99.1 d802938dex991.htm EX-99.1 17715
3 EX-99.2 d802938dex992.htm EX-99.2 50634
7 GRAPHIC g802938ex99_2p10g1.jpg GRAPHIC 222490
8 GRAPHIC g802938ex99_2p11g1.jpg GRAPHIC 352244
9 GRAPHIC g802938ex99_2p12g1.jpg GRAPHIC 382045
10 GRAPHIC g802938ex99_2p13g1.jpg GRAPHIC 263240
11 GRAPHIC g802938ex99_2p14g1.jpg GRAPHIC 184027
12 GRAPHIC g802938ex99_2p15g1.jpg GRAPHIC 381386
13 GRAPHIC g802938ex99_2p16g1.jpg GRAPHIC 268984
14 GRAPHIC g802938ex99_2p17g1.jpg GRAPHIC 244467
15 GRAPHIC g802938ex99_2p18g1.jpg GRAPHIC 120606
16 GRAPHIC g802938ex99_2p19g1.jpg GRAPHIC 307160
17 GRAPHIC g802938ex99_2p1g1.jpg GRAPHIC 137545
18 GRAPHIC g802938ex99_2p20g1.jpg GRAPHIC 308140
19 GRAPHIC g802938ex99_2p21g1.jpg GRAPHIC 134398
20 GRAPHIC g802938ex99_2p22g1.jpg GRAPHIC 223332
21 GRAPHIC g802938ex99_2p23g1.jpg GRAPHIC 274276
22 GRAPHIC g802938ex99_2p24g1.jpg GRAPHIC 319883
23 GRAPHIC g802938ex99_2p25g1.jpg GRAPHIC 203345
24 GRAPHIC g802938ex99_2p26g1.jpg GRAPHIC 396925
25 GRAPHIC g802938ex99_2p27g1.jpg GRAPHIC 342567
26 GRAPHIC g802938ex99_2p28g1.jpg GRAPHIC 182246
27 GRAPHIC g802938ex99_2p29g1.jpg GRAPHIC 255702
28 GRAPHIC g802938ex99_2p2g1.jpg GRAPHIC 620468
29 GRAPHIC g802938ex99_2p30g1.jpg GRAPHIC 230802
30 GRAPHIC g802938ex99_2p31g1.jpg GRAPHIC 368378
31 GRAPHIC g802938ex99_2p32g1.jpg GRAPHIC 296890
32 GRAPHIC g802938ex99_2p33g1.jpg GRAPHIC 452373
33 GRAPHIC g802938ex99_2p34g1.jpg GRAPHIC 341322
34 GRAPHIC g802938ex99_2p35g1.jpg GRAPHIC 310263
35 GRAPHIC g802938ex99_2p36g1.jpg GRAPHIC 230423
36 GRAPHIC g802938ex99_2p37g1.jpg GRAPHIC 232889
37 GRAPHIC g802938ex99_2p38g1.jpg GRAPHIC 584285
38 GRAPHIC g802938ex99_2p39g1.jpg GRAPHIC 221184
39 GRAPHIC g802938ex99_2p3g1.jpg GRAPHIC 221674
40 GRAPHIC g802938ex99_2p40g1.jpg GRAPHIC 230335
41 GRAPHIC g802938ex99_2p41g1.jpg GRAPHIC 182751
42 GRAPHIC g802938ex99_2p4g1.jpg GRAPHIC 415020
43 GRAPHIC g802938ex99_2p5g1.jpg GRAPHIC 370739
44 GRAPHIC g802938ex99_2p6g1.jpg GRAPHIC 310116
45 GRAPHIC g802938ex99_2p7g1.jpg GRAPHIC 308879
46 GRAPHIC g802938ex99_2p8g1.jpg GRAPHIC 187400
47 GRAPHIC g802938ex99_2p9g1.jpg GRAPHIC 224397
  Complete submission text file 0001193125-24-230760.txt   16565031

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vera-20241002.xsd EX-101.SCH 2836
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vera-20241002_lab.xml EX-101.LAB 18738
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vera-20241002_pre.xml EX-101.PRE 11698
58 EXTRACTED XBRL INSTANCE DOCUMENT d802938d8k_htm.xml XML 3783
Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40407 | Film No.: 241345430
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)